| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/22/2013 | WO2013122751A1 Compositions and methods for contraception |
| 08/22/2013 | WO2013121429A1 Formulations and kits for forming bioadhesive matrices |
| 08/22/2013 | WO2013121354A1 Oil-based pharmaceutical composition for the treatment of gastrointestinal diseases |
| 08/22/2013 | WO2013121175A1 Lysosome-cleavable linker |
| 08/22/2013 | WO2013093823A3 Topical oil composition for the treatment of fungal infections |
| 08/22/2013 | WO2013090861A8 Alpha-aminoamidine polymers and uses thereof |
| 08/22/2013 | WO2013090804A3 Nanoparticles with enhanced mucosal penetration or decreased inflammation |
| 08/22/2013 | WO2013087716A3 Fgfr antibody drug conjugates (adcs) and the use thereof |
| 08/22/2013 | WO2013072768A3 Synthetic derivatives of mpl and uses thereof |
| 08/22/2013 | WO2013067199A3 Subcutaneous delivery of polymer conjugates of therapeutic agents |
| 08/22/2013 | WO2013066214A3 Aerosol pharmaceutical composition of protease inhibitors and production thereof |
| 08/22/2013 | WO2012035283A8 Pharmaceutical composition |
| 08/22/2013 | US20130217865 Tumor Specific Antibody |
| 08/22/2013 | US20130217861 Methods for expression and purification of immunotoxins |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217789 Biodegradable liquogel and ph sensitive nanocarriers |
| 08/22/2013 | US20130217788 Guerbet Alcohol Mixtures and Uses Thereof |
| 08/22/2013 | US20130217787 Mixed Ethers and Uses Thereof |
| 08/22/2013 | US20130217766 Formulations for cathepsin k inhibitors |
| 08/22/2013 | US20130217742 Methods and Compositions for Increasing Solubility of Azole Drug Compounds that are Poorly Soluble in Water |
| 08/22/2013 | US20130217741 Topical pharmaceutical compositions for treatment of skin damage |
| 08/22/2013 | US20130217697 Oral pharmaceutical film formulation for bitter tasting drugs |
| 08/22/2013 | US20130217653 Formulations of canfosfamide and their preparation |
| 08/22/2013 | US20130217623 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 08/22/2013 | US20130217622 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical compostion for preventing or treating diabetes, containing same as active ingredient |
| 08/22/2013 | US20130216611 Therapeutic agent for fibroid lung |
| 08/22/2013 | US20130216609 Controlled Release Antimicrobial Compositions and Methods for the Treatment of Otic Disorders |
| 08/22/2013 | US20130216607 Zwitterionic lipids |
| 08/22/2013 | US20130216596 Nanocapsules containing microemulsions |
| 08/22/2013 | US20130216592 Particles consisting of a chitosan polyelectrolyte complex and of an anionic polysaccharide, and having improved stability |
| 08/22/2013 | US20130216571 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 08/22/2013 | US20130216561 Immunoconjugates with an Intracellularly-Cleavable Linkage |
| 08/22/2013 | US20130216539 Methods of Generation and Treatment with Modified Derivatives of HSP 70 |
| 08/22/2013 | US20130216532 Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof |
| 08/22/2013 | US20130216522 Stabilized human immunoglobulin composition |
| 08/22/2013 | US20130216494 Polymer-Conjugated MetAP2 inhibitors, and Therapeutic Methods of Use Thereof |
| 08/22/2013 | US20130216476 Use of an anti-cd71 antibody for preparing a medicament |
| 08/22/2013 | US20130213398 Dry powder formulations and methods for treating pulmonary diseases |
| 08/21/2013 | EP2628506A1 Antimicrobially active composition having a content of bispyridinium alkane (octenidine dihydrochloride) |
| 08/21/2013 | EP2628489A1 PEG oligomer-fentanyl conjugates |
| 08/21/2013 | EP2628488A1 Sustained-release pharmaceutical composition |
| 08/21/2013 | EP2627606A2 Method for purifying diatomaceous earth suitable for pharmaceutical use |
| 08/21/2013 | EP2627358A1 Pretargeting kit, method and agents used therein |
| 08/21/2013 | EP2627350A1 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders |
| 08/21/2013 | EP2627347A1 Uses of macrophage mannose receptor to screen compounds and uses of these compounds |
| 08/21/2013 | EP2627319A1 Pharmaceutical compositions containing a dgat1 inhibitor |
| 08/21/2013 | EP2627318A2 Formulation suitable for stabilizing proteins, which is free of mammalian excipients |
| 08/21/2013 | EP2627316A1 Pharmaceutical formulation for histone deacetylase inhibitors |
| 08/21/2013 | EP2627315A1 Composition for treating cancer by the controlled release of an active substance |
| 08/21/2013 | EP2627173A1 Clevidipine emulsion formulations containing antimicrobial agents |
| 08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2013 | CN103260648A Compositions and methods for the prevention and treatment of cancer |
| 08/21/2013 | CN103260621A Topical localized isoxazoline formulation |
| 08/21/2013 | CN103260620A Topical localized isoxazoline formulation comprising glycofurol |
| 08/21/2013 | CN103260617A Novel pharmaceutical formulation comprising NSAID and cyclodextrin |
| 08/21/2013 | CN103260616A Stabilizer of acetaminophen |
| 08/21/2013 | CN103260610A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain ? |
| 08/21/2013 | CN103260609A Solid retard formulations based on solid dispersions |
| 08/21/2013 | CN103260606A Compositions and methods for cardiac therapy |
| 08/21/2013 | CN103260604A Viscous nutritional composition |
| 08/21/2013 | CN103254427A Acid-sensitive degradation-controllable serial polymers with branched structures and preparation method thereof |
| 08/21/2013 | CN103254375A Polymethyl hexafluorobutyl acrylate amphiphilic segmented copolymers and preparation method thereof |
| 08/21/2013 | CN103254338A Preparation method of medicinal polyvinylpyrrolidone with high molecular weight |
| 08/21/2013 | CN103254317A Anti-CD20 monoclonal antibody-aplysiatoxin conjugate as well as preparation method and application thereof |
| 08/21/2013 | CN103254315A Recombinant TAT-MANF (trans-activator of transcription-mesencephalic astrocyte derived neurotrophic factor) fusion protein and application thereof |
| 08/21/2013 | CN103254280A Short peptide with tumor cell targeting combination capability and application thereof |
| 08/21/2013 | CN103254279A Polypeptide conjugate of paclitaxel or docetaxel |
| 08/21/2013 | CN103251963A Mixture for curing liver cancer |
| 08/21/2013 | CN103251956A Matrine-montmorillonite nano composite and preparation method thereof |
| 08/21/2013 | CN103251955A High-molecular targeted drug carrier used for bladder tumor perfusion treatment, and preparation method thereof |
| 08/21/2013 | CN103251949A Nanometer composite material having gold/tetra-sulfide hepta-copper core-shell structure and preparation method thereof |
| 08/21/2013 | CN103251942A Folic-adenovirus tumor targeting compound and preparation method thereof |
| 08/21/2013 | CN103251941A Animal viral vaccine pulsatile release system, and preparation method and application thereof |
| 08/21/2013 | CN103251940A Vaccine |
| 08/21/2013 | CN103251929A Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 08/21/2013 | CN103251737A Yindan capsule |
| 08/21/2013 | CN103251716A Swelling-diminishing pain-erasing ointment and preparation method thereof |
| 08/21/2013 | CN103251700A Red sage root and pseudo-ginseng tablet |
| 08/21/2013 | CN103251655A Preparation method of Chinese medicinal composition for treating rheumatoid arthritis |
| 08/21/2013 | CN103251597A Naltrexone long acting formulations and methods of use |
| 08/21/2013 | CN103251596A 7-ethyl-10-hydroxycamptothecin amphiphilic polymer prodrug as well as preparation method and nano-particles thereof |
| 08/21/2013 | CN103251595A Technology for preparing folic acid-glucan-camptothecin composite nanoparticles through supercritical CO2 anti-solvent method |
| 08/21/2013 | CN103251593A Repaglinide/metformin composition |
| 08/21/2013 | CN103251573A Protein micro/nano sphere carrying antitumor chemotherapeutic medicine and preparation method of protein micro/nano sphere |
| 08/21/2013 | CN103251572A Preparation method of theaflavin enteric microcapsule, as well as product prepared by preparation method and application of product |
| 08/21/2013 | CN103251571A Potassium ion binding polymers for pharmaceutical compositions |
| 08/21/2013 | CN103251570A Preparation method for idebenone microcapsule through ultrasonic inclusion by beta-cyclodextrin |
| 08/21/2013 | CN103251568A Oral solid preparation containing polyene phosphatidyl choline and preparation method thereof |
| 08/21/2013 | CN103251566A Tablet and preparation method thereof |
| 08/21/2013 | CN103251565A Voriconazole freeze-dried powder injection for injection and preparation method thereof |
| 08/21/2013 | CN103251564A Azacitidine for injection and preparation method thereof |
| 08/21/2013 | CN103251563A Stable granular medicine composition containing epinastine or hydrochloride thereof |
| 08/21/2013 | CN103251562A Method for improving stability and shelf-life of liposome complexes |
| 08/21/2013 | CN103251561A Double-sensitive disintegrating nano-sized vesica medicine carrier preparation and preparation method thereof |
| 08/21/2013 | CN103251560A Liposome wrapped medicine intercalation hydrotalcite-like nano hybrid complex and preparation method thereof |
| 08/21/2013 | CN103251558A Preparation of high drug loading multifunction nanometer drug with combination treatment effect |
| 08/21/2013 | CN103251557A Felodipine nano suspension and preparation method thereof |
| 08/21/2013 | CN103251556A Aprepitant nanosuspension and preparation method thereof |
| 08/21/2013 | CN103251554A Stable edaravone injection and preparation method thereof |
| 08/21/2013 | CN103251553A Aqueous solution of silybin glycocides and external skin treatment composition |